share_log

於2024年6月26日舉行的股東週年大會上提呈的決議案的投票結果

POLL RESULTS OF THE RESOLUTIONS PROPOSEDAT THE ANNUAL GENERAL MEETING HELD ON JUNE 26, 2024

HKEX ·  Jun 26 22:51

Summary by Futu AI

商湯集團股份有限公司(「商湯」)於2024年6月26日召開股東週年大會,並通過所有提案。會議中,股東批准了包括審核合併財務報表、董事及核數師報告,以及重選徐立博士等人為董事的決議。此外,股東亦通過了購回及發行股份的一般授權,並續聘羅兵咸永道會計師事務所為核數師。商湯還宣布委任林達華博士為執行董事,任期三年。同時,股東大會批准了對2022年受限制股份單位計劃的修訂,並終止首次公開發售前的相關計劃。所有決議案均獲得超過半數的贊成票,並無股東在會前表明反對或棄權。會議的投票結果顯示,除了對於發行新股份的授權外,其他決議案均獲得接近全票通過。
商湯集團股份有限公司(「商湯」)於2024年6月26日召開股東週年大會,並通過所有提案。會議中,股東批准了包括審核合併財務報表、董事及核數師報告,以及重選徐立博士等人為董事的決議。此外,股東亦通過了購回及發行股份的一般授權,並續聘羅兵咸永道會計師事務所為核數師。商湯還宣布委任林達華博士為執行董事,任期三年。同時,股東大會批准了對2022年受限制股份單位計劃的修訂,並終止首次公開發售前的相關計劃。所有決議案均獲得超過半數的贊成票,並無股東在會前表明反對或棄權。會議的投票結果顯示,除了對於發行新股份的授權外,其他決議案均獲得接近全票通過。
Shangtang Group Co., Ltd. (“Shangtang”) held its annual shareholder meeting on June 26, 2024 and approved all proposals. In the meeting, shareholders approved the resolution to review the consolidated financial statements, the reports of the directors and auditors, and to re-elect directors such as Dr. Xu Libo. In addition, shareholders also approved the general authorization to repurchase and issue shares, and re-appointed PricewaterhouseCoopers as the auditors. Shangtang also announced the appointment of Dr. Lin Dahua as an executive director for a term of three years. At the same time, the shareholders' meeting approved the amendment to the restricted share unit plan for 2022 and terminated the relevant plan before the initial public offering. All resolutions received more than half of the affirmative votes, and no shareholders expressed opposition or abstention before the meeting. The voting results of the meeting showed that all resolutions except for the authorization to issue new shares were approved by almost all the votes.
Shangtang Group Co., Ltd. (“Shangtang”) held its annual shareholder meeting on June 26, 2024 and approved all proposals. In the meeting, shareholders approved the resolution to review the consolidated financial statements, the reports of the directors and auditors, and to re-elect directors such as Dr. Xu Libo. In addition, shareholders also approved the general authorization to repurchase and issue shares, and re-appointed PricewaterhouseCoopers as the auditors. Shangtang also announced the appointment of Dr. Lin Dahua as an executive director for a term of three years. At the same time, the shareholders' meeting approved the amendment to the restricted share unit plan for 2022 and terminated the relevant plan before the initial public offering. All resolutions received more than half of the affirmative votes, and no shareholders expressed opposition or abstention before the meeting. The voting results of the meeting showed that all resolutions except for the authorization to issue new shares were approved by almost all the votes.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.